Skip to main content
. 2023 Apr 18;23:70. doi: 10.1186/s12911-023-02168-6

Table 3.

Descriptive statistics of the study population – Experiments 1 and 2

Overall Study Sample Mortality
Total 1,749 218 (12.5%)
Age Group  < 70 843 (48.2%) 48 (5.7%)
 ≥ 70 906 (51.8%) 170 (18.8%)
Sex Female 606 (34.6%) 91 (15.0%)
Male 1,143 (65.4%) 127 (11.1%)
Type of AMI Anterior STEMI 300 (17.2%) 44 (14.7%)
Other STEMI 785 (44.9%) 123 (15.7%)
NSTEMI 664 (38.0%) 51 (7.7%)
N.º of Comorbidities 0 560 (32.0%) 17 (3.0%)
1 470 (26.9%) 51 (10.9%)
2 312 (17.8%) 57 (18.3%)
3 189 (10.8%) 41 (21.7%)
4 123 (7.0%) 33 (26.8%)
5 67 (3.8%) 11 (16.4%)
6 22 (1.3%) 5 (22.7%)
7 5 (0.3%) 2 (40.0%)
8 1 (0.1%) 1 (100.0%)
Comorbidities Anaemia 220 (12.6%) 29 (13.2%)
Cancer 88 (5.0%) 25 (18.4%)
Cardiogenic Shock 105 (6.0%) 74 (70.5%)
Diabetes with complications 150 (8.6%) 21 (14.0%)
Diabetes without complications 395 (22.6%) 53 (13.4%)
Cardiac dysrhythmia 481 (27.5%) 102 (21.2%)
Cerebrovascular Disease 204 (11.7%) 31 (15.2%)
Pulmonary oedema 96 (5.5%) 28 (29.2%)
Acute Kidney Failure 359 (20.5%) 66 (18.1%)
Chronic Kidney Failure 356 (20.4%) 54 (15.2%)
Respiratory infection 209 (11.9%) 45 (21.5%)
Surgical Intervention Yes 1,077 (61.6%) 93 (8.6%)
No 672 (38.4%) 125 (18.6%)
Number of tranfers between services  < = 2 1472(84.2%) 180(12.2%)
 < = 5 248(14.2%) 24(9.7%)
 < = 8 26(1.5%) 4(15.4%)
 > 8 3(0.2%) 1(33.3%)